185 related articles for article (PubMed ID: 7812003)
1. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis.
Kawano MM; Mihara K; Huang N; Tsujimoto T; Kuramoto A
Blood; 1995 Jan; 85(2):487-94. PubMed ID: 7812003
[TBL] [Abstract][Full Text] [Related]
2. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.
Tsujimoto T; Lisukov IA; Huang N; Mahmoud MS; Kawano MM
Blood; 1996 Apr; 87(8):3375-83. PubMed ID: 8605355
[TBL] [Abstract][Full Text] [Related]
3. Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: role of bone marrow stromal cells and interleukin 6.
Roldán E; Brieva JA
Eur J Immunol; 1991 Nov; 21(11):2671-7. PubMed ID: 1936115
[TBL] [Abstract][Full Text] [Related]
4. Identification of early plasma cells in peripheral blood and their clinical significance.
Harada Y; Kawano MM; Huang N; Mahmoud MS; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1996 Jan; 92(1):184-91. PubMed ID: 8562394
[TBL] [Abstract][Full Text] [Related]
5. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression.
Medina F; Segundo C; Campos-Caro A; González-García I; Brieva JA
Blood; 2002 Mar; 99(6):2154-61. PubMed ID: 11877292
[TBL] [Abstract][Full Text] [Related]
6. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
7. IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells.
Crooks GM; Hao QL; Petersen D; Barsky LW; Bockstoce D
J Immunol; 2000 Sep; 165(5):2382-9. PubMed ID: 10946261
[TBL] [Abstract][Full Text] [Related]
8. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
[TBL] [Abstract][Full Text] [Related]
9. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
10. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.
Shah AJ; Smogorzewska EM; Hannum C; Crooks GM
Blood; 1996 May; 87(9):3563-70. PubMed ID: 8611678
[TBL] [Abstract][Full Text] [Related]
11. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells.
Choe J; Choi YS
Eur J Immunol; 1998 Feb; 28(2):508-15. PubMed ID: 9521060
[TBL] [Abstract][Full Text] [Related]
12. VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion.
Roldán E; García-Pardo A; Brieva JA
J Exp Med; 1992 Jun; 175(6):1739-47. PubMed ID: 1588291
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
15. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
[TBL] [Abstract][Full Text] [Related]
16. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).
Van Riet I; De Greef C; Aharchi F; Woischwill C; De Waele M; Bakkus M; Lacor P; Schots R; Van Camp B
Leukemia; 1997 Feb; 11(2):284-93. PubMed ID: 9009094
[TBL] [Abstract][Full Text] [Related]
18. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
[TBL] [Abstract][Full Text] [Related]
19. Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma.
Nishinarita S; Shimada H; Ito T; Namiki H; Kawahira H; Sawada U; Horie T
J Int Med Res; 1998; 26(1):37-42. PubMed ID: 9513075
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
